Study of Efficacy, Safety, and Tolerability of LYS006, in Patients With Mild to Moderate Ulcerative Colitis
Clinical trial NCT04074590 · TERMINATED
Trial details
- NCT number
- NCT04074590
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-03
- Primary completion
- 2022-11-07
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.